Wilmington, NC, United States of America

Scott Burnside

USPTO Granted Patents = 7 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Scott Burnside

Introduction

Scott Burnside, an accomplished inventor based in Wilmington, North Carolina, has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Burnside has developed innovative solutions that address various health challenges.

Latest Patents

Among Scott Burnside's latest patents is a groundbreaking tablet composition. This patent involves a tablet comprising 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol or a pharmaceutically acceptable salt thereof. His innovations in pharmaceutical tablets showcase his commitment to enhancing drug formulation and delivery.

Career Highlights

Throughout his career, Scott has demonstrated a strong dedication to advancing pharmaceutical science. He has worked with prestigious organizations such as Celgene Corporation and Servier Pharmaceuticals LLC, where he has contributed to the development of various therapeutic solutions. His work has not only yielded patents but has also played a role in advancing the pharmaceutical industry.

Collaborations

Scott Burnside has collaborated with talented professionals, including Darshan Parikh and Sreenivas S Bhat. These collaborations have enriched his work and contributed to the successful development of innovative pharmaceutical products.

Conclusion

In conclusion, Scott Burnside's contributions to the field of pharmaceuticals through his inventions and patents substantiate his role as an influential inventor. His continuous pursuit of innovation highlights the importance of research and development in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…